UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Number of items: 176.

Article

(1996) Quantification of X-chromosome inactivation patterns in haematological samples using the DNA PCR-based HUMARA assay. Leukemia , 10 (2) pp. 362-367.

(1996) The beta subunit common to the GM-CSF, IL-3 and IL-5 receptors is highly polymorphic but pathogenic point mutations in patients with acute myeloid leukaemia (AML) are rare. Leukemia , 10 (1) pp. 123-129.

Abeysinghe, RD; Roberts, PJ; Cooper, CE; MacLean, KH; Hider, RC; Porter, JB; (1996) The environment of the lipoxygenase iron binding site explored with novel hydroxypyridinone iron chelators. J BIOL CHEM , 271 (14) 7965 - 7972. Gold open access

Akbar, AN; Borthwick, NJ; Wickremasinghe, RG; Panayiotidis, P; Pilling, D; Bofill, M; Krajewski, S; ... Salmon, M; + view all (1996) Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of anti-apoptotic (bcl-2, bcl-x(L)) but not pro-apoptotic (bax, bcl-x(S)) gene expression. EUR J IMMUNOL , 26 (2) 294 - 299.

Anderson, J; Melville, R; Jeffries, DJ; Norman, J; Welch, J; Graham, D; Fadojutimi, M; ... Chard S Harindra, V; + view all (1996) Ethnic differences in women with HIV infection in Britain and Ireland. The study group for the mrc collaborative study of HIV infection in women. AIDS , 10 (1) pp. 89-93.

Anderson, J; Melville, R; Jeffries, DJ; Norman, J; Welch, J; Graham, D; Fadojutimi, M; ... Harindra, V; + view all (1996) Ethnic differences in women with HIV infection in Britain and Ireland. AIDS , 10 (1) 89 - 93.

Arnett, KL; Moses, JH; Williams, F; Marsh, SG; Bodmer, JG; Parham, P; Middleton, D; (1996) HLA-A *2607: sequence of a novel A*26 subtype predicted by DNA typing which shares the MA2.1 epitope with A*02, B*57 and B*58. Tissue Antigens , 47 (5) pp. 422-425.

Atsumi, T; Khamashta, MA; Amengual, O; Donohoe, S; Mackie, I; Hughes, GRV; (1996) Beta2-glycoprotein I (beta 2GPI) dependent ''anti protein C'' antibody in antiphospholipid syndrome (APS). ARTHRITIS RHEUM , 39 (9) 397 - 397.

Atsumi, T; Khamashta, MA; Donohoe, S; Mackie, I; Ichikawa, K; Koike, T; Hughes, GRV; (1996) Interaction between human monoclonal anticardiolipin antibodies (Mo-aCLs), protein C and beta2-glycoprotein I (beta 2GPI). ARTHRITIS RHEUM , 39 (9) 396 - 396.

Battini, JL; Rodrigues, P; Müller, R; Danos, O; Heard, JM; (1996) Receptor-binding properties of a purified fragment of the 4070A amphotropic murine leukemia virus envelope glycoprotein. J Virol , 70 (7) pp. 4387-4393.

BennettGuerrero, E; Sorohan, JG; Ayuso, L; Cardigan, RA; Newman, MF; Mackie, IJ; Mythen, MG; (1996) Effect of long-cardiopulmonary bypass duration on serum aprotinin pharmacokinetics using a high dose regimen. ANESTH ANALG , 82 (4) SCA10 - SCA10.

BennettGuerrero, E; Sorohan, JG; Howell, ST; Ayuso, L; Cardigan, RA; Newman, MF; Mackie, IJ; ... Mythen, MG; + view all (1996) Maintenance of therapeutic: Plasma aprotinin levels during prolonged cardiopulmonary bypass using a large-dose regimen. ANESTH ANALG , 83 (6) 1189 - 1192.

Bernard, T; Evans, JPM; Sullivan, AM; Gale, RE; Linch, DC; (1996) Mutations of the granulocyte colony-stimulating factor receptor in Kostmann's syndrome may be transient and may not herald leukaemic transformation. BLOOD , 88 (10) 2177 - 2177.

Bernard, T; Gale, RE; Linch, DC; (1996) Analysis of granulocyte colony stimulating factor receptor isoforms, polymorphisms and mutations in normal haemopoietic cells and acute myeloid leukaemia blasts. British Journal of Haematology , 93 (3) pp. 527-533. 10.1046/j.1365-2141.1996.d01-1696.x.

Bernard, T; Gale, RE; Linch, DC; (1996) Analysis of granulocyte colony stimulating factor receptor isoforms, polymorphisms and mutations in normal haemopoietic cells and acute myeloid leukaemia blasts. BRIT J HAEMATOL , 93 (3) 527 - 533.

Boogaerts, MA; Brugger, W; Carella, AM; CortesFunes, H; Fibbe, WE; Hows, J; Khayat, D; ... Testa, NG; + view all (1996) Peripheral blood progenitor cell transplantation: Where do we stand? Chairman's summary of the European School of Oncology Task Force Meeting 'Peripheral Blood Progenitor Cells' held September 29-30, 1995 - Introduction. ANN ONCOL , 7 1 - 4.

Borthwick, NJ; Akbar, AN; MacCormac, LP; Salmon, M; Yong, KL; (1996) Selective migration of highly differentiation primed T cells across human umbilical vein endothelial cells (HUVEC). IMMUNOLOGY , 89 T204-T204.

Boultwood, J; Fidler, C; Mills, KI; Frodsham, PM; Kusec, R; Gaiger, A; Gale, RE; ... Wainscoat, JS; + view all (1996) Amplification of mitochondrial DNA in acute myeloid leukaemia. BRIT J HAEMATOL , 95 (2) 426 - 431.

Buday, L; Khwaja, A; Sipeki, S; Farago, A; Downward, J; (1996) Interactions of Cbl with two adaptor proteins, Grb2 and Crk, upon T cell activation. J BIOL CHEM , 271 (11) 6159 - 6163. Gold open access

Bunce, M; Barnardo, MC; Procter, J; Marsh, SG; Vilches, C; Welsh, KI; (1996) High resolution HLA-C typing by PCR-SSP: identification of allelic frequencies and linkage disequilibria in 604 unrelated random UK Caucasoids and a comparison with serology. Tissue Antigens , 48 (6) pp. 680-691.

Cardigan, RA; HamiltonDavies, C; McDonald, S; Purdy, G; Mackie, IJ; Webb, AR; Machin, SJ; (1996) Haemostatic changes in the pulmonary blood during cardiopulmonary bypass. BLOOD COAGUL FIBRIN , 7 (5) 567 - 577.

Cardigan, RA; Mackie, IJ; Machin, SJ; (1996) The effect of heparin and its neutralisation on functional assays for factor VIIa, factor VII and TFPI. THROMBOSIS RESEARCH , 84 (4) pp. 237-242. 10.1016/S0049-3848(96)00183-1.

Chakraverty, R; Davidson, S; Peggs, K; Stross, P; Garrard, C; Littlewood, TJ; (1996) The incidence and cause of coagulopathies in an intensive care population. BRIT J HAEMATOL , 93 (2) 460 - 463.

Champseix, C; Maréchal, V; Khazaal, I; Schwartz, O; Fournier, S; Schlegel, N; Dranoff, G; ... Lehn, P; + view all (1996) A cell surface marker gene transferred with a retroviral vector into CD34+ cord blood cells is expressed by their T-cell progeny in the SCID-hu thymus. Blood , 88 (1) pp. 107-113.

Charlton, PA; Faint, RW; Bent, F; Bryans, J; ChicarelliRobinson, I; Mackie, I; Machin, S; (1996) Evaluation of a low molecular weight modulator of human plasminogen activator inhibitor-1 activity. THROMB HAEMOSTASIS , 75 (5) 808 - 815.

Chavda, N; Mackie, IJ; Porter, JB; Harrison, P; Patterson, K; Machin, SJ; (1996) Rapid flow cytometric quantitation of reticulated platelets in whole blood. PLATELETS , 7 (4) pp. 189-194. 10.3109/09537109609023578.

Chopra, R; Kendall, G; Gale, RE; Thomas, NSB; Linch, DC; (1996) Expression of two alternatively spliced forms of the 5' untranslated region of the GM-CSF receptor alpha chain mRNA. EXP HEMATOL , 24 (6) 755 - 762.

Chopra, R; Kendall, G; Gale, RE; Thomas, NSB; Linch, DC; (1996) Expression of two alternatively spliced forms of the 5' untranslated region of the GM-CSF receptor α chain mRNA. Experimental Hematology , 24 (6) pp. 755-762.

Cometta, A; Calandra, T; Gaya, H; Zinner, SH; de Bock, R; Del Favero, A; Bucaneve, G; ... Glauser, MP; + view all (1996) Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program. Antimicrob Agents Chemother , 40 (5) pp. 1108-1115.

Cooper, CE; Lynagh, GR; Hoyes, KP; Hider, RC; Cammack, R; Porter, JB; (1996) The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase. J BIOL CHEM , 271 (34) 20291 - 20299. Gold open access

Davis, BA; Cervi, P; Amin, Z; Moshi, G; Shaw, P; Porter, J; (1996) Retinoic acid syndrome: Pulmonary computed tomography (CT) findings. LEUKEMIA LYMPHOMA , 23 (1-2) 113 - 117.

Devereux, S; Wheadon, H; Khwaja, A; Linch, DC; (1996) An insertion in the extracellular domain of the human GM-CSF receptor alpha subunit reduces surface expression by a post-translational mechanism. BRIT J HAEMATOL , 93 12 - 12.

Dominguez, E; Lowdell, MW; Perez, I; Madrigal, A; Cohen, SBA; (1996) Natural killer cell function is altered by freezing in DMSO. IMMUNOLOGY , 89 E52 - E52.

Durosinmi, MA; Matutes, E; Ryan, K; Nathwani, A; Hedges, M; Catovsky, D; (1996) Royal Marsden teaching cases. An elderly man with weight loss and anaemia. LEUKEMIA LYMPHOMA , 23 (1-2) 181 - &.

Fidler, C; Mills, KI; Frodsham, PM; Kusec, R; Gaiger, A; Gale, RE; Linch, DC; ... Wainscoat, JS; + view all (1996) Amplification of mitochondrial DNA in CGL in transformation. BLOOD , 88 (10) 925 - 925.

Fielding, AK; Goldstone, AH; Sullivan, AM; Watts, MJ; Jamieson, E; Linch, DC; (1996) Peripheral blood stem cell support does not accelerate haemopoietic recovery from miniBEAM chemotherapy. BONE MARROW TRANSPL , 18 (3) 507 - 511.

Freeburn, RW; Gale, RE; Linch, DC; (1996) The beta chain of the GM-CSF receptor can dimerize in the absence of specific alpha chains and ligand. BLOOD , 88 (10) 2635 - 2635.

Freeburn, RW; Gale, RE; Wagner, HM; Linch, DC; (1996) The beta subunit common to the GM-CSF, IL-3 and IL-5 receptors is highly polymorphic but pathogenic point mutations in patients with acute myeloid leukaemia (AML) are rare. LEUKEMIA , 10 (1) 123 - 129.

Gale, RE; Bunch, C; Moir, DJ; Patterson, KG; Goldstone, AH; Linch, DC; (1996) Demonstration of developing myelodysplasia acute myeloid leukaemia in haematologically normal patients after high-dose chemotherapy and autologous bone marrow transplantation using X-chromosome inactivation patterns. BRIT J HAEMATOL , 93 (1) 53 - 58.

Gale, RE; Bunch, C; Moir, DJ; Patterson, KG; Goldstone, AH; Linch, DC; (1996) Demonstration of developing myelodysplasia/acute myeloid leukaemia in haematologically normal patients after high-dose chemotherapy and autologous bone marrow transplantation using X-chromosome inactivation patterns. British Journal of Haematology , 93 (1) pp. 53-58. 10.1046/j.1365-2141.1996.4751014.x.

Gale, RE; Fielding, AK; Linch, DC; (1996) Difficulties of using clonal analysis for diagnosis of haematological disorders in elderly patients. BRIT J HAEMATOL , 93 787 - 787.

Gale, RE; Mein, CA; Linch, DC; (1996) Quantification of X-chromosome inactivation patterns in haematological samples using the DNA PCR-based HUMARA assay. LEUKEMIA , 10 (2) 362 - 367.

Gardiner, C; Mackie, IJ; MAchin, SJ; (1996) An ELISA for free protein S using monoclonal antibodies. BRIT J HAEMATOL , 93 124 - 124.

Hacein-Bey, H; Cavazzana-Calvo, M; Le Deist, F; Dautry-Varsat, A; Hivroz, C; Rivière, I; Danos, O; ... De Saint Basile, G; + view all (1996) gamma-c gene transfer into SCID X1 patients' B-cell lines restores normal high-affinity interleukin-2 receptor expression and function. Blood , 87 (8) pp. 3108-3116.

Hampton, KK; Daly, M; Greaves, M; Lowe, GDO; Forbes, CD; Machin, SJ; Mackie, I; ... Baigent, C; + view all (1996) Thrombotic disorders - Discussion. J ROY COLL PHYS LOND , 30 (4) 381 - 385.

Harrison, CN; Hudson, GV; Perry, A; Anderson, L; MacMillan, A; Devereux, S; Goldstone, AH; (1996) Beam and ABMT/PBSCT may reduce the risk of secondary leukaemia in Hodgkin's disease: A case-control analysis with the BNLI database. BLOOD , 88 (10) 1036 - 1036.

Harrison, P; Cardigan, R; Harrison, C; Addison, I; Chavda, N; Chitolie, A; Machin, SJ; (1996) Delayed effect of desmopressin on circulating neutrophils and monocytes. BRIT J HAEMATOL , 95 (3) 570 - 571.

Hawkins, AE; Zuckerman, MA; Briggs, M; Gilson, RJC; Goldstone, AH; Brink, NS; Tedder, RS; (1996) Hepatitis B nucleotide sequence analysis: Linking an outbreak of acute hepatitis B to contamination of a cryopreservation tank. J VIROL METHODS , 60 (1) 81 - 88.

Hill, ME; MacLennan, KA; Cunningham, DC; Hudson, BV; Burke, M; Clarke, P; DiStefano, F; ... Linch, DC; + view all (1996) Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: A British National Lymphoma Investigation Study. BLOOD , 88 (3) 1046 - 1051.

Hoyes, KP; Porter, JB; (1996) Cell cycle synchronisation by 3-hydroxypyridin-4-one iron chelators. Methods in Cell Science , 18 (2) pp. 127-133. 10.1007/BF00122163.

Hudson, M; Chitolie, A; Hutton, RA; Smith, MSH; Pounder, RE; Wakefield, AJ; (1996) Thrombotic vascular risk factors in inflammatory bowel disease. GUT , 38 (5) 733 - 737.

Ireland, HA; Boisclair, MD; Taylor, J; Thompson, E; Thein, SL; Girolami, A; De Caterina, M; ... Lane, DA; + view all (1996) Two novel (R(-11)C; T394D) and two repeat missense mutations in the protein C gene associated with venous thrombosis in six kindreds. Human mutation , 7 pp. 176-179.

Ireland, HA; Boisclair, MD; Taylor, J; Thompson, E; Thein, SL; Girolami, A; DeCaterina, M; ... Lane, DA; + view all (1996) Two novel (R(-11)C; T394D) and two repeat missense mutations in the protein C gene associated with venous thrombosis in six kindreds. HUM MUTAT , 7 (2) 176 - 179.

Jamal, R; Gale, RE; Thomas, NSB; Wheatley, K; Linch, DC; (1996) Reduced or abnormal expression of pRb in AML blasts is not a major prognostic factor. BRIT J HAEMATOL , 93 256 - 256.

Jamal, R; Gale, RE; Thomas, NSB; Wheatley, K; Linch, DC; (1996) The retinoblastoma gene (rb1) in acute myeloid leukaemia: Analysis of gene rearrangements, protein expression and comparison of disease outcome. British Journal of Haematology , 94 (2) pp. 342-351. 10.1046/j.1365-2141.1996.d01-1804.x.

Jamal, R; Gale, RE; Thomas, NSB; Wheatley, K; Linch, DC; (1996) The retinoblastoma gene (rbl) in acute myeloid leukaemia: Analysis of gene rearrangements, protein expression and comparison of disease outcome. BRIT J HAEMATOL , 94 (2) 342 - 351.

Jamal, R; Thomas, NSB; Gale, RE; Linch, DC; (1996) Variable expression of p16 protein in patients with acute myeloid leukemia without gross rearrangements at the DNA. LEUKEMIA , 10 (4) 629 - 636.

Jamal, R; Thomas, NSB; Gale, RE; Linch, DC; (1996) Variable expression of p16 protein in patients with acute myeloid leukemia without gross rearrangements at the DNA level. Leukemia , 10 (4) pp. 629-636.

Jones, DW; Gallimore, MJ; Winter, M; Cohen, H; Mackie, I; Machin, S; (1996) Heterozygous factor XII deficiency within a group of blood donors in Kent. BRIT J HAEMATOL , 93 127 - 127.

Kayyali, R; Porter, JB; Hider, RC; (1996) Enzyme inhibition by hydroxypyridinone iron chelators. European Journal of Pharmaceutical Sciences , 4 (S1) S106-S106. 10.1016/S0928-0987(97)86313-0.

Khwaja, A; Hallberg, B; Warne, PH; Downward, J; (1996) Networks of interaction of p120(cbl) and p130(cas) with Crk and Grb2 adaptor proteins. ONCOGENE , 12 (12) 2491 - 2498.

Koh, MBC; Lowdell, MW; Prentice, HG; (1996) Selective removal of alloreactive lymphocytes from peripheral blood mononuclear cell preparations. BLOOD , 88 (10) 1001 - 1001.

Kusec, R; Gaiger, A; Gale, RE; Linch, DC; Littlewood, TJ; Moss, PAH; Wainscoat, JS; (1996) Amplification of mitochondrial DNA in acute myeloid leukaemia. British Journal of Haematology , 95 (2) pp. 426-431. 10.1046/j.1365-2141.1996.d01-1922.x.

Langabeer, SE; Walker, H; Wheatley, K; Burnett, AK; Goldstone, AH; Linch, DC; (1996) Frequency of CBFB/MYH11 fusion transcripts in acute myelomonocytic leukaemia (AML M4). BRIT J HAEMATOL , 93 235 - 235.

Lavau, C; Heard, JM; Danos, O; Dejean, A; (1996) Retroviral vectors for the transduction of the PML-RARalpha fusion product of acute promyelocytic leukemia. Exp Hematol , 24 (4) pp. 544-551.

Liesner, R; Mackie, I; Cookson, J; McDonald, S; Chitolie, A; Evans, J; Hann, I; (1996) Prothrombotic changes in children with sickle cell disease and other red cell disorders. BRIT J HAEMATOL , 93 32 - 32.

Linch, DC; (1996) Intensive chemotherapy and bone marrow transplantation: The challenge of fungal infections - Proceedings of a satellite symposium to the 21st annual meeting of the European Group for Blood and Marrow Transplantation (EBMT), held in Davos, Switzerland on 19 March 1995 - Introduction. EUR J HAEMATOL , 56 5 - 6.

Linch, DC; (1996) Intensive chemotherapy and bone marrow transplantation: the challenge of fungal infections. Introduction. Eur J Haematol Suppl , 57 pp. 5-6.

Linch, DC; (1996) Management of the histologically aggressive non-Hodgkin's lymphomas in adults. BAILLIERE CLIN HAEM , 9 (4) 689 - 706.

Linch, DC; (1996) Non-Hodgkin's lymphomas - Preface. BAILLIERE CLIN HAEM , 9 (4) R9 - R9.

Linch, DC; Hudson, BV; Hancock, BW; Hoskin, PJ; Cunningham, DC; Newland, AC; Milligan, DW; ... Hudson, GV; + view all (1996) A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: A British national lymphoma investigation report. BRIT J CANCER , 74 (2) 318 - 322.

Linch, DC; Watts, MJ; (1996) Standards for PBSC mobilisation and collection. ANNALS OF ONCOLOGY , 7 9 - 10.

Little, AM; Mason, A; Marsh, SG; Parham, P; (1996) HLA-C typing of eleven Papua New Guineans: identification of an HLA-Cw4/Cw2 hybrid allele. Tissue Antigens , 48 (2) pp. 113-117.

Lowdell, MW; Bainbridge, DR; (1996) External quality assurance for CD34 cell enumeration - Results of a preliminary national trial. BONE MARROW TRANSPL , 17 (5) 849 - 853.

Lowdell, MW; Bainbridge, DR; (1996) External quality assurance for CD34 cell enumeration--results of a preliminary national trial. Royal Microscopical Society Clinical Flow Cytometry Group QA Schemes. Bone Marrow Transplant , 17 (5) pp. 849-853.

Lowdell, MW; Ray, N; Craston, R; Prentice, HG; (1996) Interferon-alpha treatment after autologous bone marrow transplantation and the development of in vitro anti-leukaemic immune reactivity. EXP HEMATOL , 24 (9) 361 - 361.

Lowdell, MW; Ray, N; Craston, R; Prentice, HG; (1996) Interferon-alpha treatment after autologous bone marrow transplantation and the development of in vitro anti-leukaemic immune reactivity. BRIT J HAEMATOL , 93 477 - 477.

Lowdell, MW; Ray, N; Craston, R; Prentice, HG; (1996) The application of flow cytometry for the detection and investigation of leukaemia-specific immunity. IMMUNOLOGY , 89 SI40 - SI40.

Macdonald, I; Anderson, R; Corbett, T; Galatowicz, G; Lowdell, M; Prentice, HG; (1996) Development of leukaemia vaccines by gene transfer of costimulatory and cytokine genes to AML cells using adeno-associated virus. BRITISH JOURNAL OF HAEMATOLOGY , 93 p. 478.

Machin, SJ; Lawrie, A; Mackie, IJ; Robinson, GE; Guillebaud, J; (1996) Do third generation oral contraceptives alter levels of prothrombotic risk factors? BRIT J HAEMATOL , 93 18 - 18.

Machin, SJ; Mackie, IJ; Chitolie, A; Lawrie, AS; (1996) Near patient testing (NPT) in haemostasis - A synoptic review. CLIN LAB HAEMATOL , 18 (2) 69 - 74.

Mackinnon, S; (1996) Donor leukocyte infusions for relapsed leukemia after allogeneic BMT. HEMATOLOGY AND CELL THERAPY , 38 (5) 461 - 462.

Maclean, KH; Porter, JB; (1996) Contrasting apoptotic induction in bone marrow precursors and thymocytes by hydroxyurea and iron chelators. BLOOD , 88 (10) 1950 - 1950.

Marsh, SG; (1996) Nomenclature for factors of the HLA System, update June 1996. Eur J Immunogenet , 23 (5) pp. 391-392.

Marsh, SG; (1996) Nomenclature for factors of the HLA System, update May 1996. Eur J Immunogenet , 23 (5) pp. 389-390.

Marsh, SG; (1996) Nomenclature for factors of the HLA system, update April 1996. Tissue Antigens , 48 (1) pp. 69-70.

Marsh, SG; (1996) Nomenclature for factors of the HLA system, update April 1996. Eur J Immunogenet , 23 (4) pp. 333-334.

Marsh, SG; (1996) Nomenclature for factors of the HLA system, update February 1996. Eur J Immunogenet , 23 (4) 329-.

Marsh, SG; (1996) Nomenclature for factors of the HLA system, update February 1996. WHO Nomenclature Committee for factors of the HLA system. Tissue Antigens , 47 (4) 360-.

Marsh, SG; (1996) Nomenclature for factors of the HLA system, update January 1996. Eur J Immunogenet , 23 (3) pp. 241-242.

Marsh, SG; (1996) Nomenclature for factors of the HLA system, update January 1996. The Who Nomenclature Committee for Factors of the HLA System. Hum Immunol , 46 (1) 67-.

Marsh, SG; (1996) Nomenclature for factors of the HLA system, update June 1996. Tissue Antigens , 48 (3) pp. 233-234.

Marsh, SG; (1996) Nomenclature for factors of the HLA system, update March 1996. Tissue Antigens , 47 (5) 454-.

Marsh, SG; (1996) Nomenclature for factors of the HLA system, update March 1996. Eur J Immunogenet , 23 (4) 331-.

Marsh, SG; (1996) Nomenclature for factors of the HLA system, update May 1996. WHO Nomenclature Committee for Factors of the HLA system. Tissue Antigens , 48 (2) pp. 141-142.

Marsh, SG; (1996) Nomenclature for factors of the HLA system, update November 1995. Tissue Antigens , 47 (2) pp. 166-167.

Marsh, SG; (1996) Nomenclature for factors of the HLA system, update November 1995. Eur J Immunogenet , 23 (2) pp. 157-158.

Marsh, SG; (1996) Nomenclature for factors of the HLA system, update October 1995. Eur J Immunogenet , 23 (1) pp. 71-72.

Marsh, SGE; (1996) Nomenclature for factors of the HLA system, update August/September 1996. EUROPEAN JOURNAL OF IMMUNOGENETICS , 23 (6) pp. 489-490. 10.1111/j.1744-313X.1996.tb00139.x.

Marsh, SGE; (1996) Nomenclature for factors of the HLA system, update August/September 1996. TISSUE ANTIGENS , 48 (6) pp. 725-726. 10.1111/j.1399-0039.1996.tb02701.x.

Marsh, SGE; (1996) Nomenclature for factors of the HLA system, update July 1996. TISSUE ANTIGENS , 48 (5) p. 607. 10.1111/j.1399-0039.1996.tb02680.x.

Marsh, SGE; (1996) Nomenclature for factors of the HLA system, update July 1996. EUROPEAN JOURNAL OF IMMUNOGENETICS , 23 (6) p. 487. 10.1111/j.1744-313X.1996.tb00138.x.

McNally, T; Mackie, IJ; Isenberg, DA; Machin, SJ; (1996) beta(2) glycoprotein-I inhibits factor XII activation on triglyceride rich lipoproteins: The effect of antibodies from plasma of patients with antiphospholipid syndrome. THROMB HAEMOSTASIS , 76 (2) 220 - 225.

McNally, T; Mackie, IJ; Isenberg, DA; Machin, SJ; (1996) β<inf>2</inf> glycoprotein-I inhibits factor XII activation on triglyceride rich lipoproteins: The effect of antibodies from plasma of patients with antiphospholipid syndrome. Thrombosis and Haemostasis , 76 (2) pp. 220-225.

Mengubas, K; Riordan, FA; Hoffbrand, AV; Wickremasinghe, RG; (1996) Co-ordinated downregulation of bcl-2 and bax expression during granulocytic and macrophage-like differentiation of the HL60 promyelocytic leukaemia cell line. FEBS LETT , 394 (3) 356 - 360.

Mercey, D; Griffioen, A; Woronowski, H; Stephenson, J; (1996) Uptake of medical interventions in women with HIV infection in Britain and Ireland. Study Group for the MRC Collaborative Study of HIV Infection in Women. Genitourin Med , 72 (4) 281 - 282.

Mercey, D; Griffioen, A; Woronowski, H; Stephenson, J; Anderson, J; Melville, R; Jeffries, DJ; ... Harindra, V; + view all (1996) Uptake of medical interventions in women with HIV infection in Britain and Ireland. GENITOURINARY MEDICINE , 72 (4) pp. 281-282.

Milpied, N; Fielding, AK; Pearce, RM; Ernst, P; Goldstone, AH; (1996) Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. J CLIN ONCOL , 14 (4) 1291 - 1296.

Milpied, N; Fielding, AK; Pearce, RM; Ernst, P; Goldstone, AH; (1996) Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation. Journal of Clinical Oncology , 14 pp. 1291-1296.

Mollapour, E; Roberts, PJ; Kaczmarski, R; Porter, JB; Linch, DC; (1996) Defective cytokine-mediated priming of neutrophil hydrogen peroxide production in sickle cell disease. BRIT J HAEMATOL , 93 333 - 333.

Moullier, P; Salvetti, A; Bohl, D; Danos, O; Heard, JM; (1996) [Gene therapy in lysosomal diseases]. C R Seances Soc Biol Fil , 190 (1) pp. 45-51.

Moullier, P; Salvetti, A; Bohl, D; Danos, O; Heard, JM; (1996) [Gene therapy of lysosomal diseases]. Arch Pediatr , 3 Supp 65s-68s.

Mythen, MG; Purdy, GC; Mackie, IJ; Webb, AR; Machin, SJ; (1996) There is significant neutrophil degranulation both before and during cardiopulmonary by-pass. ANESTH ANALG , 82 (4) SCA26 - SCA26.

Naffakh, N; Danos, O; (1996) Gene transfer for erythropoiesis enhancement. Mol Med Today , 2 (8) pp. 343-348.

Naffakh, N; Pinset, C; Montarras, D; Li, Z; Paulin, D; Danos, O; Heard, JM; (1996) Long-term secretion of therapeutic proteins from genetically modified skeletal muscles. Hum Gene Ther , 7 (1) pp. 11-21. 10.1089/hum.1996.7.1-11.

Ng, TTC; Kanner, SB; Humphries, MJ; Wickremasinghe, RG; Nye, KE; Anderson, J; Morrow, WJW; (1996) Dysfunctional focal adhesion kinase (pp125(FAK)) expression in HIV-infected donor T-cells. IMMUNOLOGY , 89 N137 - N137.

Noble, KE; Panayiotidis, P; Collins, PW; Hoffbrand, AV; Yong, KL; (1996) Monocytes induce E-selectin gene expression in endothelial cells: role of CD11/CD18 and extracellular matrix proteins. Eur J Immunol , 26 (12) pp. 2944-2951. 10.1002/eji.1830261221.

Nouri, AME; Lowdell, M; Entazami, Z; Tezabwala, BU; Goode, A; Oliver, RTD; (1996) Comparison of immunological changes between subcutaneous and intravenous route of administration of IL-2 in cancer patients. UROLOGIA INTERNATIONALIS , 56 (1) pp. 1-5. 10.1159/000282798.

Olivieri, NF; NisbetBrown, E; Srichairatanakool, S; Dragsten, P; Hallaway, P; Hedlund, B; Porter, JB; (1996) Studies of iron excretion and non-transferrin-bound plasma iron (NTBP1), following a single infusion of hydroxyethyl starch-deferoxamine (HES-DFO): A new approach to iron chelation therapy. BLOOD , 88 (10) 1228 - 1228.

Pedersen, TL; Yong, K; Pedersen, JO; Hansen, NE; Danø, K; Plesner, T; (1996) Impaired migration in vitro of neutrophils from patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol , 95 (1) pp. 45-51.

Peniket, AJ; Hudson, GV; Anderson, L; Linch, DC; (1996) Chronic relapsing Hodgkin's disease: An analysis of 167 cases from the British national lymphoma (BNLI) database. BLOOD , 88 (10) 892 - 892.

Perry, AR; Linch, DC; (1996) The history of bone-marrow transplantation. BLOOD REVIEWS , 10 (4) 215 - 219.

Perry, AR; Mackinnon, S; (1996) Adoptive immunotherapy post bone-marrow transplantation. BLOOD REVIEWS , 10 (4) 237 - 241.

Porter, JB; (1996) Evaluation of new iron chelators for clinical use. ACTA HAEMATOL-BASEL , 95 (1) 13 - 25.

Porter, JB; Abeysinghe, RD; Marshall, L; Hider, RC; Singh, S; (1996) Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy. BLOOD , 88 (2) 705 - 713.

Porter, JB; Faherty, AM; (1996) 12 years experience of intravenous desferrioxamine using indwelling intravenous devices in thalassaemia. BRIT J HAEMATOL , 93 334 - 334.

Rai, R; Regan, L; Hadley, E; Dave, M; Cohen, H; (1996) Second-trimester pregnancy loss is associated with activated C resistance (Editor’s selection: 1997 Year Book of Obstetrics and Gynaecology and selected to be abstracted in the July 1996 issue of Focus and Opinion/Obstetrics and Gynaecology). British journal of haematology , 92 pp. 489-490.

Rai, R; Regan, L; Hadley, E; Dave, M; Cohen, H; (1996) Second-trimester pregnancy loss is associated with activated C resistance. Br J Haematol , 92 (2) pp. 489-490.

Rai, RS; Regan, L; Chitolie, A; Donald, JG; Cohen, H; (1996) Placental thrombosis and second trimester miscarriage in association with activated protein C resistance. Br J Obstet Gynaecol , 103 (8) pp. 842-844.

Rai, RS; Regan, L; Cohen, H; (1996) Complications of pregnancy after infertility treatment: awareness and prevention. Br J Obstet Gynaecol , 103 (2) pp. 191-192.

Rai, RS; Regan, L; Donald, JG; Cohen, H; (1996) Placental thrombosis and second trimester miscarriage in association with activated protein C resistance. BRIT J OBSTET GYNAEC , 103 (8) 842 - 844.

Reittie, JE; Yong, KL; Panayiotidis, P; Hoffbrand, AV; (1996) Interleukin-6 inhibits apoptosis and tumour necrosis factor induced proliferation of B-chronic lymphocytic leukaemia. Leuk Lymphoma , 22 (1-2) pp. 83-90. 10.3109/10428199609051732.

Roberts, PJ; Mollapour, E; Linch, DC; (1996) Regulation of phospholipase A(2) (PLA(2)) during differentiation of haemopoietic stem cells. BLOOD , 88 (10) 790 - 790.

Roberts, PJ; Williams, SL; Linch, DC; (1996) The regulation of neutrophil phospholipase A(2) by granulocyte-macrophage colony-stimulating factor and its role in priming superoxide production. BRIT J HAEMATOL , 92 (4) 804 - 814.

Schmitz, N; Linch, DC; Dreger, P; Goldstone, AH; Boogaerts, MA; Ferrant, A; Demuynck, HMS; ... Borkett, K; + view all (1996) Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. LANCET , 347 (8998) 353 - 357.

Shields, DA; Saharay, M; TimothyAntoine, C; Porter, JB; Scurr, JH; Smith, PDC; (1996) Neutrophil CD11b expression in patients with venous disease. PHLEBOLOGY , 11 (2) 55 - 59.

Stephenson, JM; Griffioen, A; Woronowski, H; Petruckevitch, A; Keenlyside, R; Johnson, AM; Phillips, AN; ... Doyle, C; + view all (1996) The effect of HIV diagnosis on reproductive experience. AIDS , 10 (14) pp. 1683-1687. 10.1097/00002030-199612000-00013.

Sullivan, AM; Watts, MJ; Leverett, D; Williams, CD; Goldstone, AH; Linch, DC; (1996) Failure to mobilise peripheral blood stem cells reflects poor quality bone marrow. BRIT J HAEMATOL , 93 147 - 147.

Sweetenham, JW; Taghipour, G; Linch, DC; Goldstone, AH; (1996) Thirty percent of adult patients with primary refractory Hodgkin's disease (HD) are progression free at 5 years after high dose therapy (HDT) and autologous stem cell transplantation (ASCT): Data from 290 patients reported to the EBMT. BLOOD , 88 (10) 1932 - 1932.

Tay, D; Hoffbrand, AV; Wickremasinghe, RG; (1996) Expression of c-fos and c-jun proteins and AP-1 binding activity during cell cycle progression of HL60 cells and phytohaemagglutinin-stimulated lymphocytes. Experimental Hematology , 24 (2277) 284-.

Taylor, FC; Ramsay, ME; Renton, A; Cohen, H; (1996) Methods for managing the increased workload in anticoagulant clinics. BMJ , 312 (7026) 286-. 10.1136/bmj.312.7026.286.

Theocharous, P; Lowdell, MW; Jones, A; Prentice, HG; (1996) The detection and genetic analysis of low frequency epithelial tumour cells in patients with breast cancer. BLOOD , 88 (10) 998 - 998.

Tuddenham, EG; (1996) The tissue factor-factor VII complex: recent advances towards elucidating the structure and function of the initiator of haemostasis. Haemostasis , 26 Sup pp. 20-24. 10.1159/000217235.

Vandenberghe, E; DeWolfPeeters, C; Hudson, GV; Hudson, BV; Anderson, L; Linch, DC; (1996) Outcome of mantle cell lymphomas - A study from the British National Lymphoma Investigation Group (BNLI). BRIT J HAEMATOL , 93 282 - 282.

Watts, MJ; Addison, I; Linch, DC; (1996) Comparison of progenitor cell mobilisation by glycosylated and non-glycosylated G-CSF given at a dose of 5 mu g/kg/day to normal volunteers. BLOOD , 88 (10) 1570 - 1570.

Watts, MJ; Addison, I; Sullivan, AM; Chavda, N; Jamieson, E; Hunter, M; Czaplewski, L; ... Linch, DC; + view all (1996) Effects of a single dose at BB-10010 on progenitor cell mobilization after cyclophosphamide and G-CSF. BRIT J HAEMATOL , 93 1049 - 1049.

Watts, MJ; Leverett, D; Sullivan, AM; Peniket, AJ; Perry, AR; MacMillan, A; Goldstone, AH; (1996) A comparison of ESHAP+G-CSF vs cyclophosphamide 1.5g/m(2)+G-CSF for PBSC mobilisation in pre-treated lymphoma patients: A matched pair analysis. BLOOD , 88 (10) 1571 - 1571.

Watts, MJ; Sullivan, AM; Goldstone, AH; Linch, DC; (1996) Feasibility of clinical scale CD34+ cell purification of peripheral blood stem cell harvests: Experience of 40 immunoaffinity column procedures. BRIT J HAEMATOL , 93 46 - 46.

Watts, MJ; Sullivan, AM; Leverett, D; MacMillan, AK; Patterson, K; Devereux, S; Goldstone, AH; (1996) Evaluation of the ESHAP regimen followed by G-CSF for PBSC mobilisation: A matched pairs analysis compared to low dose cyclophosphamide 1.5g/m(2) plus G-CSF. BRIT J HAEMATOL , 93 167 - 167.

Wheadon, H; Devereux, S; Khwaja, A; Linch, DC; (1996) Activation of the stat 5 and MAP kinase signalling pathways by high and intermediate affinity GM-CSF receptors. BRIT J HAEMATOL , 93 11 - 11.

Wheadon, H; Roberts, P; Linch, DC; (1996) GM-CSF receptor mediated activation of stat 5 is increased by neutrophilic differentiation in HL60 cells. BRIT J HAEMATOL , 93 85 - 85.

Wheadon, H; Roberts, PJ; Linch, DC; (1996) Differentiation-dependent changes in signal transduction mediated by the GM-CSF receptor. BLOOD , 88 (10) 784 - 784.

Williams, CD; Watts, MJ; Linch, DC; Thomas, NSB; (1996) E2F and p130 are involved in early cell cycle progression of haemopoietic CD34+ stem cells. BRIT J HAEMATOL , 93 13 - 13.

Williams, CD; Watts, MJ; Sullivan, AM; Leverett, D; Linch, DC; Goldstone, AH; (1996) Successful CD34+ cell mobilisation is predictive of a survival advantage to patients with myeloma undergoing peripheral blood stem cell transplantation. BRIT J HAEMATOL , 93 302 - 302.

Williams, SL; Roberts, PJ; Addison, IE; Mollapour, E; Czaplewski, L; Linch, DC; (1996) Studies of the effect of rhMIP-1 alpha on phagocyte function. BRIT J HAEMATOL , 93 87 - 87.

Yong, KL; (1996) Granulocyte colony-stimulating factor (G-CSF) increases neutrophil migration across vascular endothelium independent of an effect on adhesion: comparison with granulocyte-macrophage colony-stimulating factor (GM-CSF). British Journal of Haematology , 94 (1) pp. 40-47.

Yong, KL; (1996) Granulocyte colony-stimulating factor (G-CSF) increases neutrophil migration across vascular endothelium independent of an effect on adhesion: comparison with granulocyte-macrophage colony-stimulating factor (GM-CSF). Br J Haematol , 94 (1) pp. 40-47.

Yong, KL; Watts, MJ; Thomas, NSB; Sullivan, AM; Williams, C; Masek, L; Sweetenham, J; (1996) Transendothelial migration of CD34+ cells requires prior activation by growth factors and is mediated by PECAM-1. BLOOD , 88 (10) 1888 - 1888.

Book chapter

(1996) Thrombophilic defects and pregnancy loss. In: UNSPECIFIED (pp. 745-757).

Linch, DC; (1996) Intensive chemotherapy and bone marrow transplantation: The challenge of fungal infections: Introduction. In: UNSPECIFIED (pp. 5-6).

Lowdell, MW; Han, P; Dominguez, E; (1996) Immunobiology of neonatal NK cells. In: Cohen, S and Gluckman, E and Rubenstein, P and Madrigal, AJ, (eds.) Cord Blood Characteristics – role in stem cell transplantation. Martin Dunitz: London.

Ozanne, C; Cohen, H; (1996) Haemostatic defects and venous thromboembolism. In: Salmasi, M, (ed.) Angiology in practice. (pp. 443-458). Kluwer Academic

Proceedings paper

Anderson, R; Macdonald, I; Corbett, T; Lowdell, M; Prentice, HG; (1996) Interleukin 12 (IL-12) and CD80 co-expression from an adeno-associated virus vector. In: (pp. p. 593). BLACKWELL SCIENCE LTD

Bradley, SJ; Oguejiofor, NA; Hider, RC; Porter, JB; (1996) Non-transferrin bound iron (NTBI) induced by cytotoxic chemotherapy. In: BRIT J HAEMATOL. (pp. 325 - 325). BLACKWELL SCIENCE LTD

Chitolie, A; Mackie, IJ; Machin, SJ; Porter, JB; (1996) Heparin cofactor II is depleted from after incubation with normal, sickle, and thalassaemia red cells. In: BRIT J HAEMATOL. (pp. 339 - 339). BLACKWELL SCIENCE LTD

Corbett, T; Hart, S; Macdonald, I; Anderson, R; Lowdell, M; Prentice, HG; (1996) Expression of the costimulatory molecules CD80 and CD86 on myeloid leukaemic blasts. In: (pp. p. 470). BLACKWELL SCIENCE LTD

Corbett, T; Lowdell, M; Macdonald, I; Anderson, R; Prentice, HG; (1996) B7.1 is superior to B7.2 in providing costimulation for the generation of cytotoxic effectors. In: (pp. p. 360). CARDEN JENNINGS PUBL CO LTD

Flores, NA; Botchway, A; Cohen, H; Fry, CH; Sheridan, DJ; (1996) Electrophysiological changes in isolated guineapig ventricular myocytes following exposure to products of the platelet release reaction. In: J PHYSIOL-LONDON. (pp. P55 - P55). CAMBRIDGE UNIV PRESS

Morgan, CL; Ruprai, AK; Solache, A; Lowdell, M; Price, CP; Parham, P; Newman, DJ; (1996) Real-time analysis of HLA class I stability identifies a novel role for exogenous peptide. In: (pp. p. 21). ELSEVIER SCIENCE INC

Porter, JB; Abeysinghe, RD; Marshall, L; Hider, RC; Singh, S; (1996) Relationship of kinetics of desferrioxamine to removal and reappearance of non-transferrin-bound plasma iron in thalassaemia. In: BRIT J HAEMATOL. (pp. 199 - 199). BLACKWELL SCIENCE LTD

Prentice, HG; Deane, M; Anderson, R; Corbett, T; Lowdell, M; Macdonald, I; (1996) The immunotherapy of acute leukaemia; From allogeneic bone marrow transplantation to gene therapy. In: (pp. p. 359). CARDEN JENNINGS PUBL CO LTD

Scott, I; Bunce, M; Lowdell, M; OShea, J; Tiercy, JM; Prentice, G; Goldman, J; (1996) NK and CTL alloreactivity due to HLA-C mismatches in BMT. In: (pp. O435-O435). ELSEVIER SCIENCE INC

Tay, DLM; Hoffbrand, AV; Wickremasinghe, RG; (1996) Expression of c-fos and c-jun proteins and AP-1 binding activity during cell cycle progression of HL60 cells and phytohemagglutinin-stimulated lymphocytes. In: EXPERIMENTAL HEMATOLOGY. (pp. 277 - 284). CARDEN JENNINGS PUBL CO LTD

Conference item

Cohen, H; (1996) Randomized trial of aspirin versus aspirin and heparin in pregnant women with the antiphospholipid syndrome. Presented at: UNSPECIFIED, France.

Hawkins, AE; Zuckerman, MA; Goldstone, AH; Gilson, RJC; Heptonstall, J; Tedder, RS; (1996) Identification of a common source outbreak of hepatitis B infection in a bone marrow transplant facility by nucleotide sequence analysis. Presented at: Xth International Congress of Virology, Jerusalem, Israel..

Rai, R; Regan, L; Dave, M; Cohen, H; (1996) Prospective randomised trial of aspirin versus aspirin plus heparin in pregnant women with the antiphospholipid syndrome. Presented at: British society for haematology annual scientific meeting, Venice.

This list was generated on Sun Jun 16 05:24:48 2019 BST.